{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:08:03Z","timestamp":1790096883074,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015921","name":"Hengyang Science and Technology Bureau","doi-asserted-by":"publisher","award":["202330046164"],"award-info":[{"award-number":["202330046164"]}],"id":[{"id":"10.13039\/501100015921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015921","name":"Hengyang Science and Technology Bureau","doi-asserted-by":"publisher","award":["2019jh426002"],"award-info":[{"award-number":["2019jh426002"]}],"id":[{"id":"10.13039\/501100015921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002767","name":"China Hunan Provincial Science and Technology Department","doi-asserted-by":"publisher","award":["2019sk4007"],"award-info":[{"award-number":["2019sk4007"]}],"id":[{"id":"10.13039\/501100002767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31670173"],"award-info":[{"award-number":["31670173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018531","name":"Major Science and Technology Projects in Yunnan Province","doi-asserted-by":"publisher","award":["202002AA100009"],"award-info":[{"award-number":["202002AA100009"]}],"id":[{"id":"10.13039\/501100018531","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010451","name":"Health and Family Planning Commission of Hunan Province","doi-asserted-by":"publisher","award":["W20243205"],"award-info":[{"award-number":["W20243205"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010451","name":"Health and Family Planning Commission of Hunan Province","doi-asserted-by":"publisher","award":["Z2023010"],"award-info":[{"award-number":["Z2023010"]}],"id":[{"id":"10.13039\/501100010451","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017695","name":"Health Commission of Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017695","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024JJ6399"],"award-info":[{"award-number":["2024JJ6399"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.virusres.2026.199785","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T23:17:28Z","timestamp":1786576648000},"page":"199785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expression and immunogenicity of a rabies virus glycoprotein\u2013HSV-2 ICP35 fusion antigen delivered by an mRNA\u2013LNP formulation"],"prefix":"10.1016","volume":"372","author":[{"given":"Xueqi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenye","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangwei","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubo","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10101","key":"10.1016\/j.virusres.2026.199785_bib0017","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(17)31665-3","article-title":"Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial","volume":"390","author":"Alberer","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.virusres.2026.199785_bib0009","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.vaccine.2020.12.070","article-title":"Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: a phase 1 trial","volume":"39","author":"Aldrich","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virusres.2026.199785_bib0008","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3390\/vaccines7040132","article-title":"Advances in RNA vaccines for preventive indications: a case study of A vaccine against rabies","volume":"7","author":"Armbruster","year":"2019","journal-title":"Vaccines. (Basel)"},{"key":"10.1016\/j.virusres.2026.199785_bib0015","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30938","article-title":"Long-term antigen exposure irreversibly modifies metabolic requirements for T cell function","volume":"7","author":"Bettonville","year":"2018","journal-title":"Elife"},{"issue":"8","key":"10.1016\/j.virusres.2026.199785_bib0007","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3390\/vaccines13080887","article-title":"A QS21+ CpG-adjuvanted rabies virus G subunit vaccine elicits superior humoral and moderate cellular immunity","volume":"13","author":"Cao","year":"2025","journal-title":"Vaccines. (Basel)"},{"issue":"1","key":"10.1016\/j.virusres.2026.199785_bib0029","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/s42003-021-02441-2","article-title":"Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration","volume":"4","author":"Carrasco","year":"2021","journal-title":"Commun. Biol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199785_bib0019","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/1061186X.2024.2416241","article-title":"Development of non-viral targeted RNA delivery vehicles - a key factor in success of therapeutic RNA","volume":"33","author":"Choudry","year":"2025","journal-title":"J. Drug Target."},{"issue":"1","key":"10.1016\/j.virusres.2026.199785_bib0006","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev-virology-100114-055157","article-title":"Everything you always wanted to know about rabies virus (But Were Afraid to Ask)","volume":"2","author":"Davis","year":"2015","journal-title":"Annu Rev. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2026.199785_bib0014","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12943-021-01339-1","article-title":"Clinical and immunological effects of mRNA vaccines in malignant diseases","volume":"20","author":"Heine","year":"2021","journal-title":"Mol. Cancer"},{"issue":"12","key":"10.1016\/j.virusres.2026.199785_bib0023","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1021\/acs.molpharmaceut.4c00826","article-title":"Development of thermally stable mRNA-LNP delivery systems: current progress and future prospects","volume":"21","author":"Kafle","year":"2024","journal-title":"Mol. Pharmaceutics"},{"issue":"22","key":"10.1016\/j.virusres.2026.199785_bib0024","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222212344","article-title":"Increasing transfection efficiency of lipoplexes by modulating complexation solution for transient gene expression","volume":"22","author":"Kim","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virusres.2026.199785_bib0004","article-title":"Immunological identification and characterization of the capsid scaffold protein encoded by UL26.5 of Herpes Simplex Virus Type 2","volume":"11","author":"Li","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.virusres.2026.199785_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149254","article-title":"Optimizing mRNA translation efficiency through rational 5\u2032UTR and 3\u2032UTR combinatorial design","volume":"942","author":"Li","year":"2025","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.virusres.2026.199785_bib0026","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/pharmaceutics14102157","article-title":"Preparation of DSPE-PEG-cRGD modified cationic liposomes for delivery of OC-2 shRNA and the antitumor effects on breast cancer","volume":"14","author":"Liu","year":"2022","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.virusres.2026.199785_bib0021","article-title":"A perspective of lipid nanoparticles for RNA delivery","volume":"4","author":"Ma","year":"2024","journal-title":"Exploration (Beijing)"},{"issue":"4","key":"10.1016\/j.virusres.2026.199785_bib0031","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.it.2026.01.012","article-title":"The dual-adjuvant logic of mRNA vaccines","volume":"47","author":"Malewana","year":"2026","journal-title":"Trends. Immunol."},{"issue":"2","key":"10.1016\/j.virusres.2026.199785_bib0016","first-page":"274","article-title":"mRNA as a therapeutics: understanding mRNA vaccines","volume":"12","author":"O\u011fuz","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.virusres.2026.199785_bib0025","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.biomaterials.2015.11.017","article-title":"The influence of the polar head-group of synthetic cationic lipids on the transfection efficiency mediated by niosomes in rat retina and brain","volume":"77","author":"Ojeda","year":"2016","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.virusres.2026.199785_bib0013","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1038\/s41573-024-01042-y","article-title":"mRNA vaccines for infectious diseases - advances, challenges and opportunities","volume":"23","author":"Pardi","year":"2024","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"4","key":"10.1016\/j.virusres.2026.199785_bib0001","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.virusres.2026.199785_bib0018","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1023\/B:VIRU.0000025777.62826.92","article-title":"Peculiarities of herpes simplex virus (HSV) transcription: an overview","volume":"28","author":"Rajc\u00e1ni","year":"2004","journal-title":"Virus. Genes."},{"key":"10.1016\/j.virusres.2026.199785_bib0022","doi-asserted-by":"crossref","first-page":"891","DOI":"10.3762\/bjoc.17.75","article-title":"Enhanced target cell specificity and uptake of lipid nanoparticles using RNA aptamers and peptides","volume":"17","author":"Ray","year":"2021","journal-title":"Beilstein J. Org. Chem."},{"issue":"4","key":"10.1016\/j.virusres.2026.199785_bib0020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.12991\/jrp.2019.175","article-title":"In vitro preliminary studies of chitooligosaccharide coated nanostructured lipidic nanoparticles for efficient gene delivery","volume":"23","author":"\u015eenel","year":"2019","journal-title":"J. Res. Pharm."},{"issue":"4","key":"10.1016\/j.virusres.2026.199785_bib0032","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2021.01.007","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","volume":"184","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"Pt 4","key":"10.1016\/j.virusres.2026.199785_bib0003","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1099\/0022-1317-76-4-1069","article-title":"Nucleotide sequence of the herpes simplex virus type 2 gene encoding the protease and capsid protein ICP35","volume":"76","author":"Steffy","year":"1995","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.virusres.2026.199785_bib0028","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1021\/acs.molpharmaceut.2c01024","article-title":"Delivery and expression of mRNA in the secondary lymphoid organs drive immune responses to lipid nanoparticle-mRNA vaccines after intramuscular injection","volume":"20","author":"Takanashi","year":"2023","journal-title":"Mol. Pharmaceutics"},{"issue":"11","key":"10.1016\/j.virusres.2026.199785_bib0030","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.immuni.2022.10.014","article-title":"Innate immune mechanisms of mRNA vaccines","volume":"55","author":"Verbeke","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2026.199785_bib0005","unstructured":"WHO Rabies. 2024. (accessed on 1 July 2025). Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/rabies."},{"issue":"8","key":"10.1016\/j.virusres.2026.199785_bib0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3390\/vaccines12080873","article-title":"Recent advancements in mRNA vaccines: from target selection to delivery systems","volume":"12","author":"Wu","year":"2024","journal-title":"Vaccines. (Basel)"},{"issue":"24","key":"10.1016\/j.virusres.2026.199785_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413620","article-title":"Efficient mRNA delivery In vitro and In vivo using a polycharged biodegradable nanomaterial","volume":"25","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.virusres.2026.199785_bib0002","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2597629","article-title":"mRNA vaccine platforms and novel delivery systems: from mechanistic principles to clinical translation","volume":"21","author":"Yang","year":"2025","journal-title":"Hum. Vaccin. ImmunOther."},{"issue":"1","key":"10.1016\/j.virusres.2026.199785_bib0012","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41392-023-01579-1","article-title":"mRNA vaccines in disease prevention and treatment","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal. Transduct. Target. Ther."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170226001048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:12:57Z","timestamp":1790093577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170226001048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S0168170226001048"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199785","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and immunogenicity of a rabies virus glycoprotein\u2013HSV-2 ICP35 fusion antigen delivered by an mRNA\u2013LNP formulation","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2026.199785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199785"}}